US FDA approves Ionis' drug for rare genetic disorder
US FDA approves an ionic medication for a rare genetic disorder
FDA
US FDA announces new program to boost domestic drug manufacturing
US FDA announces a new program to enhance domestic drug production
Faron's bexmarilimab receives FDA orphan drug status for MDS treatment
Faron’s Bexmarilimab takes FDA or orphaned drug status for MDS treatment